Novacyt S.A. (CDI)
NCYT · AIM · Health Care · mcap £29m · 40.4p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 01 Oct 26 | Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights |
−4.8% | |
| 30 Sep 26 | Results | 2026 Interim Results
Paris, France, and Manchester, UK – 30 September 2026 – Novacyt S.A. |
−2.1% |
| 23 Sep 26 | Routine | Notice of Results | |
| 08 Sep 26 | Launch of IVDR-Certified Yourgene® DPYD Assay
Paris, France, and Manchester, UK - 8 September 2026 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a growing portfolio of integrated technologies and services, announc |
+2.4% | |
| 01 Sep 26 | Routine | Total Voting Rights | |
| 01 Sep 26 | Master Collaboration Agreement with Illumina
Agreement supports evaluation of future collaboration and product development opportunities |
+5.9% | |
| 03 Aug 26 | Liquidity Agreement Update and Total Voting Rights
Liquidity Agreement Monthly Update and Total Voting Rights |
+0.4% | |
| 28 Jul 26 | Trading update | Half-year trading update
Paris, France, and Manchester, UK - 28 July 2026 - Novacyt S.A. |
−2.4% |
| 01 Jul 26 | Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights |
+2.3% | |
| 30 Jun 26 | Routine | Result of AGM | |
| 11 Jun 26 | Results | Annual Report | |
| 10 Jun 26 | AGM Voting
Paris, France, and Manchester, UK - 10 June 2026 - Novacyt S.A. |
−4.2% | |
| 01 Jun 26 | Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights |
−3.8% | |
| 01 Jun 26 | Operational Update
The information contained within this announcement is deemed by Novacyt S.A. to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. |
−3.8% | |
| 22 May 26 | Routine | Notice of AGM | |
| 19 May 26 | Launch of Yourgene® Insight DPYD assay
Paris, France and Manchester, UK - 19 May 2026 - Novacyt S.A. |
+33.0% | |
| 07 May 26 | Board change | Directorate Change
Paris, France and Manchester, UK - 7 May 2026 - Novacyt S.A. |
+40.1% |
| 05 May 26 | Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights |
+5.5% | |
| 30 Apr 26 | Results | Full Year 2025 results
Paris, France, and Manchester, UK - 30 April 2026 - Novacyt S.A. |
−6.6% |
| 08 Apr 26 | Routine | Notice of Results and Investor Presentation | |
| 01 Apr 26 | Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights |
−2.5% | |
| 30 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 20 Mar 26 | Fundraise | Result of Preferential Subscription Rights Issue
Paris, France, and Manchester, UK - 20 March 2026 - Novacyt S.A. |
−1.7% |
| 02 Mar 26 | Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights |
−2.7% | |
| 02 Mar 26 | Fundraise | Preferential Subscription Rights Issue
The information contained within this announcement is deemed by Novacyt S.A. to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. |
−2.7% |
| 02 Mar 26 | Completion of Acquisition
Paris, France, and Manchester, UK - 2 March 2026 - Novacyt S.A. |
−2.7% | |
| 23 Feb 26 | Acquisition of Southern Cross Diagnostics
Paris, France, and Manchester, UK - 23 February 2026 - Novacyt S.A. |
+1.8% | |
| 02 Feb 26 | Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights |
−1.5% | |
| 27 Jan 26 | NIPT Tender Award
Contract signed with St George's University Hospitals NHS Foundation Trust |
−6.0% | |
| 21 Jan 26 | Trading update | Full year trading update
Paris, France and Manchester, UK - 21 January 2026 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), the international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces |
+0.7% |
| 02 Jan 26 | Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights |
+1.4% | |
| 01 Dec 25 | Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights |
−0.7% | |
| 03 Nov 25 | Liquidity Agreement Monthly Update and TVR
Liquidity Agreement Monthly Update and Total Voting Rights |
+1.0% | |
| 22 Oct 25 | Strategy update & notice of investor presentation
Paris, France, and Manchester, UK - 22 October 2025 - Novacyt S.A. |
+8.5% |
Company filings. Not investment advice.